Novartis
NVS
NVS
1,086 hedge funds and large institutions have $23.4B invested in Novartis in 2018 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 341 increasing their positions, 403 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,086
Holders Change
+59
Holders Change %
+5.74%
% of All Funds
24.24%
Holding in Top 10
40
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+81.82%
% of All Funds
0.89%
New
143
Increased
341
Reduced
403
Closed
76
Calls
$108M
Puts
$80.5M
Net Calls
+$27.4M
Net Calls Change
+$1.61M
Top Buyers
| 1 |
BlackRock
New York
|
+$678M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$491M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$156M |
| 4 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$142M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$125M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$649M |
| 2 |
Parnassus Investments
San Francisco,
California
|
-$379M |
| 3 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$88.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$78.7M |
| 5 |
Millennium Management
New York
|
-$72.4M |
